|
Volumn 90, Issue 25, 2012, Pages 12-18
|
Rethinking antibody-drug conjugates: Following the recent success of two conjugates, companies are focused on developing the next generation of the cancer technology
a
a
NONE
|
Author keywords
Antibody drug conjugates; Biotechnology; Breast cancer; Drug discovery; Pharmaceuticals; Protein engineering
|
Indexed keywords
|
EID: 84862648668
PISSN: 00092347
EISSN: 1520605X
Source Type: Trade Journal
DOI: 10.1021/cen-09025-cover Document Type: Article |
Times cited : (5)
|
References (0)
|